Quidel Corporation Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs

SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL), a leading provider of point-of-care rapid diagnostic tests, announced today that John D. Tamerius, Ph.D., currently vice president, clinical/regulatory affairs, has been promoted to senior vice president, clinical/regulatory affairs, effective November 10, 2008.

MORE ON THIS TOPIC